A Novel Therapeutic Target for Mitochondrial Dysfunction
Mitochondrial dysfunction plays a wide range of complex diseases. This deficiency in mitochondrial function can lead to cellular damage, ultimately resulting in diverse pathologies. EPT Fumarate, a novel therapeutic agent, has emerged as a promising approach for addressing this debilitating problem. EPT Fumarate functions by boosting the activity